| 缩写名/全名 |
CLIN EXP PHARMACOL P
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY |
||||||||||||||||||||||||
| ISSN号 | 0305-1870 | ||||||||||||||||||||||||
| 研究方向 | 医学-生理学 | ||||||||||||||||||||||||
| 影响因子 | 2015:2.004, 2016:2.01, 2017:2.092, 2018:2.336, 2019:2.456, | ||||||||||||||||||||||||
| 出版国家 | AUSTRALIA | ||||||||||||||||||||||||
| 出版周期 | Monthly | ||||||||||||||||||||||||
| 年文章数 | 127 | ||||||||||||||||||||||||
| 出版年份 | 1974 | ||||||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||||||
| 审稿周期(仅供参考) | 平均6月 |
||||||||||||||||||||||||
| 录用比例 | |||||||||||||||||||||||||
| 投稿链接 | http://mc.manuscriptcentral.com/cepp | ||||||||||||||||||||||||
| 投稿官网 | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-1681 | ||||||||||||||||||||||||
| h-index | 95 | ||||||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0305-1870%5BISSN%5D | ||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Long-term in vitro treatment of INS-1 rat pancreatic β-cells by unsaturated free fatty acids protects cells against gluco- and lipotoxicities via activation of GPR40 receptors. Author: Tuo Y, Feng DD, Wang DF, Sun J, Li SB, Chen C. Journal: Clin Exp Pharmacol Physiol. 2012 May;39(5):423-8. doi: 10.1111/j.1440-1681.2012.05691.x. PubMed |
| 2. | 2,3,4',5-Tetrahydroxystilbene-2-O-β-D-glucoside inhibits angiotensin II-induced cardiac fibroblast proliferation via suppression of the reactive oxygen species-extracellular signal-regulated kinase 1/2 pathway. Author: Zhang W, Chen XF, Huang YJ, Chen QQ, Bao YJ, Zhu W. Journal: Clin Exp Pharmacol Physiol. 2012 May;39(5):429-37. doi: 10.1111/j.1440-1681.2012.05692.x. PubMed |
| 3. | Calpain inhibitor MDL 28170 protects against the Ca2+ paradox in rat hearts. Author: Bi SH, Jin ZX, Zhang JY, Chen T, Zhang SL, Yang Y, Duan WX, Yi DH, Zhou JJ, Ren J. Journal: Clin Exp Pharmacol Physiol. 2012 Apr;39(4):385-92. doi: 10.1111/j.1440-1681.2012.05683.x. PubMed |
| 4. | Mechanisms mediating propofol protection of pulmonary epithelial cells against lipopolysaccharide-induced cell death. Author: Gu X, Lu Y, Chen J, He H, Li P, Yang T, Li L, Liu G, Chen Y, Zhang L. Journal: Clin Exp Pharmacol Physiol. 2012 May;39(5):447-53. doi: 10.1111/j.1440-1681.2012.05694.x. PubMed |
| 5. | KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese type 2 diabetic patients. Author: Dai XP, Huang Q, Yin JY, Guo Y, Gong ZC, Lei MX, Jiang TJ, Zhou HH, Liu ZQ. Journal: Clin Exp Pharmacol Physiol. 2012 May;39(5):462-8. doi: 10.1111/j.1440-1681.2012.05701.x. PubMed |
| 6. | NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients. Author: An HR, Wu XQ, Wang ZY, Zhang JX, Liang Y. Journal: Clin Exp Pharmacol Physiol. 2012 Jun;39(6):535-43. doi: 10.1111/j.1440-1681.2012.05713.x. PubMed |
| 7. | Expression patterns of histone deacetylases in experimental stroke and potential targets for neuroprotection. Author: Chen YT, Zang XF, Pan J, Zhu XL, Chen F, Chen ZB, Xu Y. Journal: Clin Exp Pharmacol Physiol. 2012 Sep;39(9):751-8. doi: 10.1111/j.1440-1681.2012.05729.x. PubMed |
| 8. | Simvastatin exerts cardioprotective effects and inhibits the activity of Rho-associated protein kinase in rats with metabolic syndrome. Author: Li CB, Li XX, Chen YG, Gao HQ, Bao MC, Zhang J, Bu PL, Zhang Y, Ji XP. Journal: Clin Exp Pharmacol Physiol. 2012 Sep;39(9):759-64. doi: 10.1111/j.1440-1681.2012.05730.x. PubMed |
| 9. | Genetic polymorphism of copper transporter protein 1 is related to platinum resistance in Chinese non-small cell lung carcinoma patients. Author: Xu X, Duan L, Zhou B, Ma R, Zhou H, Liu Z. Journal: Clin Exp Pharmacol Physiol. 2012 Sep;39(9):786-92. doi: 10.1111/j.1440-1681.2012.05741.x. PubMed |
| 10. | High glucose facilitates cell cycle arrest of rat bone marrow multipotent adult progenitor cells through transforming growth factor-β1 and extracellular signal-regulated kinase 1/2 signalling without changing Oct4 expression. Author: Luo M, Liu Z, Hao H, Lu T, Chen M, Lei M, Verfaillie CM, Liu Z. Journal: Clin Exp Pharmacol Physiol. 2012 Oct;39(10):843-51. doi: 10.1111/j.1440-1681.2012.05747.x. PubMed |
|
|
